Citations

Showing 10 of 108104 citations.

Too Stiff, Too Late . . . Timing Is Everything in Antiangiogenic Treatment of Liver Fibrosis
Greuter, Thomas , Shah, Vijay H.

Mayo Clinic

Hepatology | August 6, 2018 | Volume: 69 | Issue: 1 | Pages: 449-451

10.1002/hep.30124 | PMID 30070720 Get It

Usual interstitial pneumonia: A distinct group within interstitial pneumonia with autoimmune features? – Reply
Kelly, Bryan T. , Moua, Teng , Kelly, Bryan, Kelly, Bryan, Moua, Teng

Mayo Clinic

Respirology | August 6, 2018 | Volume: 23 | Issue: 10 | Pages: 959-959

10.1111/resp.13379 | PMID 30070408 Get It

See Letter
A Three‐Pronged Epigenetic Approach to the Treatment of Hepatocellular Carcinoma
Hlady, Ryan A. , Robertson, Keith D. , Robertson, Keith D

Mayo Clinic

Hepatology | August 6, 2018 | Volume: 68 | Issue: 4 | Pages: 1226-1228

10.1002/hep.30133 | PMID 30070376 Get It

Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women
Long, Beverly, Morillo, Arena Del Mar, Wentzensen, Nicolas , Long, Beverly J, Clarke, Megan A. , Arbyn, Marc , Bakkum‐Gamez, Jamie N.

Mayo Clinic

JAMA Internal Medicine | August 6, 2018 | Volume: 178 | Issue: 9 | Pages: 1210

10.1001/jamainternmed.2018.2820 | PMID 30083701 Get It

Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau
Kang, Silvia S. , Ebbert, Mark , Baker, Kelsey E., Cook, Casey , Wang, Xuewei , Sens, Jonathon , Kocher, Jeanne-Pierre, Petrucelli, Leonard , Fryer, John Denis , Ebbert, Mark T W , Sens, Jonathon P, Fryer, John D

Mayo Clinic

Journal of Experimental Medicine | August 6, 2018 | Volume: 215 | Issue: 9 | Pages: 2235-2245

10.1084/jem.20180653 | PMID 30082275 Get It

Alzheimer’s disease (AD) is an age-associated neurodegenerative disease characterized by amyloidosis, tauopathy, and activation of microglia, the brain resident innate immune cells. We show that a RiboTag translational profiling approach can bypass biases due to cellular enrichment/cell sorting. Using this approach in models of amyloidosis, tauopathy, and aging, we revealed a common set of alterations and identified a central APOE-driven network that converged on CCL3 and CCL4 across all conditions. Notably, aged females demonstrated a significant exacerbation of many of these shared transcripts in this APOE network, revealing a potential mechanism for increased AD susceptibility in females. This study has broad implications for microglial transcriptomic approaches and provides new insights into microglial pathways associated with different pathological aspects of aging and AD.
Drosophila melanogaster as a function-based high-throughput screening model for antinephrolithiasis agents in kidney stone patients
Ali, Sohrab N. , Dayarathna, Thamara, Ali, Aymon N., Osumah, Tijani , Cooper, Tyler T. , Zhang, Dongxing , Kim, Dajung , Kim, Rachel , Amant, Andre St., Tailly, Thomas , Yang, Jun , Luyt, Len, Burton, Jeremy P. , Razvi, Hassan , Leong, Hon S. , Leong, Hon S , Ahmed, Mohamed E. , Power, Nicholas Edgar , Amant, André H. St. , Hou, Jinqiang , Yang, Jun, Spagnuolo, Paul A.

Mayo Clinic

Disease Models & Mechanisms | August 6, 2018 | Volume: 11 | Issue: 11 | Pages: No page available

10.1242/dmm.035873 | PMID 30082495 Get It

ABSTRACT Kidney stone disease involves the aggregation of stone-forming salts consequent to solute supersaturation in urine. The development of novel therapeutic agents for this predominantly metabolic and biochemical disorder have been hampered by the lack of a practical pre-clinical model amenable to drug screening. Here, Drosophila melanogaster, an emerging model for kidney stone disease research, was adapted as a high-throughput functional drug screening platform independent of the multifactorial nature of mammalian nephrolithiasis. Through functional screening, the therapeutic potential of a novel compound commonly known as arbutin that specifically binds to oxalate, a key component of kidney calculi, was identified. Through isothermal titration calorimetry, high-performance liquid chromatography and atomic force microscopy, arbutin was determined to interact with calcium and oxalate in both free and bound states, disrupting crystal lattice structure, growth and crystallization. When used to treat patient urine samples, arbutin significantly abrogated calculus formation in vivo and outperformed potassium citrate in low pH urine conditions, owing to its oxalate-centric mode of action. The discovery of this novel antilithogenic compound via D. melanogaster, independent of a mammalian model, brings greater recognition to this platform, for which metabolic features are primary outcomes, underscoring the power of D. melanogaster as a high-throughput drug screening platform in similar disorders. This is the first description of the use of D. melanogaster as the model system for a high-throughput chemical library screen. This article has an associated First Person interview with the first authors of the paper.
Identification and Characterization of a Phase-Variable Element That Regulates the Autotransporter UpaE in Uropathogenic Escherichia coli
Battaglioli, Eric , Goh, Kelvin G. K. , Atruktsang, Tashi, Schwartz, Kevin J., Schembri, Mark A. , Welch, Rodney A. , Schembri, M A , Welch, R A

Mayo Clinic

mBio | August 6, 2018 | Volume: 9 | Issue: 4 | Pages: No page available

10.1128/mbio.01360-18 | PMID 30087170 Get It

ABSTRACT Uropathogenic Escherichia coli (UPEC) is the most common etiologic agent of uncomplicated urinary tract infection (UTI). An important mechanism of gene regulation in UPEC is phase variation that involves inversion of a promoter-containing DNA element via enzymatic activity of tyrosine recombinases, resulting in biphasic, ON or OFF expression of target genes. The UPEC reference strain CFT073 has five tyrosine site-specific recombinases that function at two previously characterized promoter inversion systems, fimS and hyxS . Three of the five recombinases are located proximally to their cognate target elements, which is typical of promoter inversion systems. The genes for the other two recombinases, IpuA and IpuB, are located distal from these sites. Here, we identified and characterized a third phase-variable invertible element in CFT073, ipuS , located proximal to ipuA and ipuB . The inversion of ipuS is catalyzed by four of the five CFT073 recombinases. Orientation of the element drives transcription of a two-gene operon containing ipuR , a predicted LuxR-type regulator, and upaE , a predicted autotransporter. We show that the predicted autotransporter UpaE is surface located and facilitates biofilm formation as well as adhesion to extracellular matrix proteins in a K-12 recombinant background. Consistent with this phenotype, the ipuS ON condition in CFT073 results in defective swimming motility, increased adherence to human kidney epithelial cells, and a positive competitive kidney colonization advantage in experimental mouse UTIs. Overall, the identification of a third phase switch in UPEC that is regulated by a shared set of recombinases describes a complex phase-variable virulence network in UPEC. IMPORTANCE Uropathogenic Escherichia coli (UPEC) is the most common cause of urinary tract infection (UTI). ON versus OFF phase switching by inversion of small DNA elements at two chromosome sites in UPEC regulates the expression of important virulence factors, including the type 1 fimbria adhesion organelle. In this report, we describe a third invertible element, ipuS , in the UPEC reference strain CFT073. The inversion of ipuS controls the phase-variable expression of upaE , an autotransporter gene that encodes a surface protein involved in adherence to extracellular matrix proteins and colonization of the kidneys in a murine model of UTI.
Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases
Lindor, Keith D. , Bowlus, Christopher L. , Mayo, Marlyn J. , Bowlus, Christopher L , Boyer, James L. , Levy, Cynthia

Mayo Clinic

Hepatology | August 5, 2018 | Volume: 69 | Issue: 1 | Pages: 394-419

10.1002/hep.30145 | PMID 30070375 Get It

Normal Variant Occipital Pneumatization
Tomblinson, Courtney M. , Deep, Nicholas L. , Fletcher, Geoffrey P. , Nelson, Kent D., Patel, Ameet C. , Weindling, Steven M. , Lane, John I. , Hoxworth, Joseph M.

Mayo Clinic

Otology & Neurotology | August 5, 2018 | Volume: 39 | Issue: 9 | Pages: e872-e875

10.1097/mao.0000000000001947 | PMID 30080763 Get It

Objective: Evaluate prevalence and pattern of occipital pneumatization (OP). Patients: Individuals with imaging evidence of OP on computed tomography (CT). Intervention(s): High resolution CT scans of the temporal bone. Main Outcome Measure: The prevalence and pattern of OP on 1000 CT scans performed at a large academic healthcare system. Results: OP had a prevalence of 11.8% (n = 118) while occipital condyle pneumatization occurred in only 0.3%. Occipital air cells were right-sided in 27.1% (n = 32), left-sided in 51.7% (n = 61), and bilateral in 21.2% (n = 25), and OP was contiguous with the occipitomastoid suture. In cases of unilateral OP, the contralateral jugular foramen demonstrated relative enlargement ( p = 0.006), but a direct association could not be established. Conclusions: The occipital bone is an accessory site of skull base pneumatization in 11.8% of the population undergoing temporal bone CT, while air cell extension into the occipital condyle occurs more rarely. These occipital air cells have a left-sided predilection and are always in direct proximity to the occipitomastoid suture, suggesting developmental egress from the mastoid. OP is a normal variant and lacks features of craniocervical pneumatization, which is a rare disorder.